Imaging Amino Acid Neurotransmitter Responses to a Single Subanesthetic Dose of Ketamine in Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy

被引:0
|
作者
Milak, Matthew [1 ]
Mulhern, Stephanie [1 ]
Proper, Caitlin [1 ]
Parter, Amy [1 ]
Kegeles, Lawrence S. [1 ]
Ogden, Todd [1 ]
Mao, Xiangling [1 ]
Rodriguez, Carolyn [1 ]
Oquendo, Maria [1 ]
Suckow, Raymond [1 ]
Cooper, Thomas [1 ]
Shungu, Dikoma [1 ]
Mann, J. John [1 ]
机构
[1] Columbia Univ, New York, NY USA
关键词
proton magnetic resonance spectroscopy; glutamate/glutamine (Glx); Major Depressive Disorder; gamma aminobutyric acid (GABA); AMPA/mTOR pathway;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
M220
引用
收藏
页码:S259 / S260
页数:2
相关论文
共 50 条
  • [1] Amino Acid Neurotransmitter Response to a Single Subanesthetic Dose of Ketamine Monitored in Major Depressive Disorder In Vivo by Proton Magnetic Resonance Spectroscopy
    Milak, Matthew S.
    Proper, Caitlin J.
    Mulhern, Stephanie T.
    Parter, Amy L.
    Kegeles, Lawrence S.
    Ogden, R. Todd
    Mao, Xiangling
    Rodriguez, Carolyn I.
    Oquendo, Maria A.
    Suckow, Raymond F.
    Cooper, Thomas B.
    Shungu, Dikoma C.
    Mann, J. John
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 93S - 93S
  • [2] A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
    M S Milak
    C J Proper
    S T Mulhern
    A L Parter
    L S Kegeles
    R T Ogden
    X Mao
    C I Rodriguez
    M A Oquendo
    R F Suckow
    T B Cooper
    J G Keilp
    D C Shungu
    J J Mann
    Molecular Psychiatry, 2016, 21 : 320 - 327
  • [3] A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
    Milak, M. S.
    Proper, C. J.
    Mulhern, S. T.
    Parter, A. L.
    Kegeles, L. S.
    Ogden, R. T.
    Mao, X.
    Rodriguez, C. I.
    Oquendo, M. A.
    Suckow, R. F.
    Cooper, T. B.
    Keilp, J. G.
    Shungu, D. C.
    Mann, J. J.
    MOLECULAR PSYCHIATRY, 2016, 21 (03) : 320 - 327
  • [4] Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder
    Price, Rebecca B.
    Shungu, Dikoma C.
    Mao, Xiangling
    Nestadt, Paul
    Kelly, Chris
    Collins, Katherine A.
    Murrough, James W.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (09) : 792 - 800
  • [5] Magnetic resonance spectroscopy imaging of GABA and glutamate in major depressive disorder
    Sanacora, G
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 102S - 102S
  • [6] Proton magnetic resonance spectroscopy of late-life major depressive disorder
    Chen, Cheng-Sheng
    Chiang, I-Chan
    Li, Chun-Wei
    Lin, Wei-Chen
    Lu, Chia-Ying
    Hsieh, Tsyh-Jyi
    Liu, Gin-Chung
    Lin, Hsiu-Fen
    Kuo, Yu-Ting
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2009, 172 (03) : 210 - 214
  • [7] Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy
    Ritter, Christopher
    Buchmann, Andreas
    Muller, Sabrina Theresia
    Volleberg, Martin
    Haynes, Melanie
    Ghisleni, Carmen
    Noeske, Ralph
    Tuura, Ruth
    Hasler, Gregor
    JAMA PSYCHIATRY, 2022, 79 (12) : 1209 - 1216
  • [8] In Vivo Proton Magnetic Resonance Spectroscopy Study of the Relationships Between Lactate, Depression Severity, and Ketamine Treatment in Major Depressive Disorder
    Lapidus, Kyle
    Murrough, James
    Mao, Xiangling
    Ogden, Todd
    Dubin, Marc
    Schwartz, Jaclyn
    Iosifescu, Dan
    Mathew, Sanjay
    Charney, Dennis
    Shungu, Dikoma
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S512 - S513
  • [9] Prefrontal metabolic abnormalities in major depressive disorder: a proton magnetic resonance spectroscopy study
    Portella, M. J.
    Morgan-Ferrando, R.
    Gomez-Anson, B.
    De Diego-Adelino, J.
    Puigdemont, D.
    Perez-Egea, R.
    Alvarez, E.
    Ruscalleda, J.
    Perez, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S423 - S424
  • [10] Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions
    Correll, GE
    Futter, GE
    PAIN MEDICINE, 2006, 7 (01) : 92 - 95